Computerized community cholesterol control (4C): Meeting the challenge of secondary prevention

Israel Medical Association Journal

Volumn 11, Issue 1, 2009, Pages 23-29

  Gilutz, Harel ^a   Novack, Lena ^a   Shvartzman, Pesach ^a   Zelingher, Julian ^b   Bonneh, Dan Y ^a,c   Henkin, Yaakov ^a   Maislos, Maximo ^d   Peleg, Roni ^a   Liss, Zvis ^a,c   Rabinowitz, Gab ^a   Vardy, Daniel ^c   Zahger, Doron ^a   Ilia, Reuven ^a   Leibermann, Niki ^b   Porath, Avi ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b CLALIT HEALTH SERVICES   (Israel)

^c Central Administration   (Israel)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Compliance; Computerized reminders; Dyslipidemia; Secondary prevention; Treatment gap

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; AUTOMATION; COMPUTER PROGRAM; CORONARY ARTERY DISEASE; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG POTENCY; DYSLIPIDEMIA; EVENT FREE SURVIVAL; FEMALE; HOSPITAL READMISSION; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT MONITORING; PILOT STUDY; SECONDARY PREVENTION; TREND STUDY; ANALYSIS OF VARIANCE; CLINICAL TRIAL; COMMUNITY CARE; COMPUTER ASSISTED DRUG THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECISION SUPPORT SYSTEM; DISEASE COURSE; ISRAEL; METHODOLOGY; ORGANIZATION AND MANAGEMENT; RANDOMIZED CONTROLLED TRIAL; STATISTICS;

AGED; ANALYSIS OF VARIANCE; COMMUNITY HEALTH SERVICES; CORONARY ARTERY DISEASE; DECISION SUPPORT SYSTEMS, CLINICAL; DISEASE PROGRESSION; DRUG THERAPY, COMPUTER-ASSISTED; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; ISRAEL; MALE; MEDICATION ADHERENCE; SECONDARY PREVENTION;

EID: 65349118760     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with Coronary Artery Disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-9.
2. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-22.
3. Grover SA, Ho V, Lavoie F, et al. The importance of indirect costs in primary cardiovascular disease prevention: can we save lives and money with statin? Arch Intern Med 2003; 163: 333-9.
4. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
5. Wood D. Recommendations of the Second Joint Task Force of European and other societies on coronary prevention. Eur Heart J 1998; 19: 1434-503.
6. Harats D, Leibovitz E, Maislos M, et al. for the HOLEM Study Group for cardiovascular risk assessment and treatment to target low density lipoprotein levels in hospitalized ischemic heart disease patients: results of the HOLEM Study. IMAJ 2005; 7: 355-9.
7. Gavish D, Leibovitz E, Elly I, Shargorodsky M, Zimlichman R. Follow-up in a lipid clinic improves the management of risk factors in cardiovascular disease patients. IMAJ 2002; 4: 694-7.
8. Benner JS, Glynn RJ, Mogun H, et al. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002; 288(4): 455-61.
9. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999; 282: 1458-65.
10. Garr DR, Ornstein SM, Jenkins RG, et al. The effect of routine use of computer-generated preventive reminders in a clinical practice. Am J Prev Med 1993; 9(1): 55-61.
11. Hunt DL, Haynes RB, Hanna SE, et al. Effects of computer-based clinical decision support systems on physician performance and patient outcomes: a systematic review. JAMA 1998; 280(15): 1339-46.
12. Johnston ME, Langton KB, Haynes RB, et al. Effects of computer-based clinical decision support systems on clinician performance and patient outcome. A critical appraisal of research. Ann Intern Med 1994; 120(2): 135-42.
13. Balas EA, Austin SM, Mitchell JA, et al. The clinical value of computerized information services. A review of 98 randomized clinical trials. Arch Fam Med 1996; 5: 271-8.
14. Shea S, DuMouchel W, Bahamonde L. A meta-analysis of 16 randomized controlled trials to evaluate computer-based clinical reminder systems for preventive care in the ambulatory setting. JAMA 1996; 3(6): 399-409.
15. Hunt DL, Haynes RB, Hanna SE, et al. Effects of computer-based clinical decision support systems on physician performance and patient: a systematic review. JAMA 1998; 280: 1339-46.
16. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40(5): 373-83.
17. Rubinstein A. Detection and treatment of high blood cholesterol for prevention of coronary artery disease attitude of the Israeli Society of Atherosclerosis. Harefuah 1995; 128(9): 551-6 (Hebrew).
18. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002; 288: 462-7.
19. McCormick LS, Black DM, Waters D, et al., for the AVERT investigators. rationale, design, and baseline characteristics of a trial comparing aggressive lipid lowering with atorvastatin versus revascularization treatments (AVERT). Am J Cardiol 1997; 80(9): 1130-3.
20. Campbell NC, Thain J, Dean HG, et al. Secondary prevention in coronary artery disease: baseline survey of provision in general practice. BMJ 1998; 316: 1430-4.
21. Gilutz H, Zelingher J, Bonneh D, et al. Is there a ceiling for lipid lowering compliance? Computerized community cholesterol control (4C). 2nd Scientific Conference on Compliance in Healthcare and Research, Washington DC; May 2004 (Abstract).
22. Avorn J, Monette J, Lacour A, et al. Persistence of use of lipid-lowering medications: a cross-national study. JAMA 1998; 279(18): 1458-62.
23. Hod H, Gotlieb S, Green M, et al. Trends in management, morbidity and mortality of patients with acute myocardial infarction hospitalized in the last decade. Harefuah 2006; 145(5): 326-31, 400 (Hebrew).
24. Garg AG, Adhikari NK, McDonald H, et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes. A systematic review. JAMA 2005; 293: 1223-38.
25. Kawamoto K, Houlihan CA, Balas EA, Lobach DF. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ 2005; 330: 765.